Less MI, Stroke on DOAC in Sinus-Rhythm HF: Post-Hoc COMMANDER-HF Less MI, Stroke on DOAC in Sinus-Rhythm HF: Post-Hoc COMMANDER-HF

Rivaroxaban didn ' t protect patients from death from progressive heart failure, but it apparently cut the risk for some thrombotic events, potentially pointing to a new role for oral anticoagulation.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Cardiology News Source Type: news